This trial is active, not recruiting.

Condition metabolic syndrome
Sponsor Medical Universtity of Lodz
Start date December 2010
End date August 2011
Trial size 300 participants
Trial identifier NCT01268696, RNN/202/10/KE


Metabolic syndrome is a combination of medical disorders that increase the risk of developing cardiovascular disease and diabetes. The exact mechanisms of the complex pathways of metabolic syndrome are not yet completely known. The pathophysiology is extremely complex and has been only partially elucidated. Most patients are older, obese, sedentary, and have a degree of insulin resistance. Stress can also be a contributing factor. The most important factors are:

weight, genetics, aging, sedentary lifestyle,excess caloric intake. In our study we will assess the role of some polymorphisms in the pathology of metabolic syndrome.

United States No locations recruiting
Other countries No locations recruiting

Study Design

Observational model case control
Time perspective prospective
healthy volunteers
Patients with metabolic syndrome

Eligibility Criteria

Male or female participants from 18 years up to 80 years old.

Inclusion Criteria: - patients with metabolic syndrome according to IDF,AHA and NHLBI 2009 Exclusion Criteria: - diabetes type 1 - cancer - not consent - steroid therapy - alcohol or drug abuse - chronic inflammatory disease - pregnancy or lactation - severe hypothyroidism - immunosuppressive treatment - operation or severe injury during the last month

Additional Information

Official title Genetic Assessment of the Patients With Metabolic Syndrome in Polish Population
Description Eligibility criteria to the study: - patients with metabolic syndrome - with written consent
Trial information was received from ClinicalTrials.gov and was last updated in July 2011.
Information provided to ClinicalTrials.gov by Medical Universtity of Lodz.